Is there evidence that daily supplementation with nicotinamide mononucleotide (NMN) and resveratrol provides health benefits?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

No Strong Evidence Supports Daily NMN and Resveratrol Supplementation for Health Benefits

Based on current evidence, I cannot recommend routine daily supplementation with NMN and resveratrol for general health benefits, as there is insufficient evidence demonstrating meaningful improvements in mortality, morbidity, or quality of life in humans.

Evidence Assessment

Guideline Framework

The available guidelines address general supplement use but do not specifically cover NMN or resveratrol. The USPSTF guidelines on vitamin supplementation establish an important precedent: insufficient evidence exists to recommend for or against most antioxidant supplements for preventing cancer or cardiovascular disease 1. This framework of requiring robust evidence before recommending supplements should apply equally to NMN and resveratrol.

Research Evidence Shows Mixed and Concerning Signals

Safety Concerns

The most recent and highest-quality evidence reveals potential harm:

  • NMN and NR supplementation promoted atherosclerosis in ApoE-/- mice despite improving dyslipidemia and fatty liver 2. This 2025 study demonstrates dose-dependent effects, with doses around 100 mg/kg showing less harm, but typical human equivalent doses (300-500 mg/kg in mice) worsened atherosclerotic plaques even after just 2 months.
  • This finding is particularly concerning because it shows that improvements in metabolic markers (lipids, fatty liver) do not translate to improved cardiovascular outcomes—the opposite occurred.

Limited Human Evidence

The 2026 systematic review and meta-analysis found 3:

  • No significant effects on body weight, BMI, fasting glucose, HbA1c, or lipid profiles
  • Only a slight decrease in diastolic blood pressure
  • Short-term safety appears acceptable, but no clear metabolic benefits were demonstrated
  • Studies were limited to 14 days to 24 weeks—far too short to assess long-term safety or meaningful clinical outcomes

Mechanistic Studies Don't Translate to Clinical Benefit

While animal studies show NMN combined with resveratrol can increase NAD+ levels in specific tissues 4, and NMN may benefit specialized conditions like chemotherapy-induced ovarian damage 5, these findings:

  • Do not demonstrate benefits for healthy individuals
  • Do not address mortality, cardiovascular events, or cancer prevention
  • May not translate to humans given the atherosclerosis findings in animal models

Clinical Reasoning

Why Not Recommend?

  1. No proven benefit on hard outcomes: No evidence of reduced mortality, cardiovascular events, cancer, or improved quality of life in healthy adults
  2. Potential cardiovascular harm: The atherosclerosis promotion in animal models 2 is a red flag that cannot be dismissed
  3. Guideline precedent: Following USPSTF logic, supplements require positive evidence of benefit before recommendation—not just absence of obvious short-term harm 1

Common Pitfalls to Avoid

  • Don't confuse surrogate markers with clinical outcomes: Increased NAD+ levels or improved lipid panels mean nothing if atherosclerosis worsens
  • Don't assume "natural" equals safe: The beta-carotene experience (increased lung cancer in smokers) 1 demonstrates supplements can cause unexpected harm
  • Don't extrapolate from specialized populations: Benefits in chemotherapy patients or aged oocytes 5 don't apply to healthy individuals seeking anti-aging effects

Practical Recommendations

For patients asking about NMN and resveratrol:

  • Explain that current evidence does not support routine use for health benefits or longevity
  • Emphasize the atherosclerosis concern from recent animal studies 2
  • Redirect focus to proven interventions: healthy diet rich in fruits and vegetables, regular exercise, and avoiding smoking
  • If patients insist on supplementation despite counseling, advise against exceeding 100 mg/kg equivalent doses and monitoring cardiovascular risk factors closely

The evidence hierarchy matters: A 2026 systematic review showing no metabolic benefits 3 combined with 2025 data showing atherosclerosis promotion 2 outweighs earlier mechanistic studies or specialized population research.

References

Related Questions

Should a generally healthy adult take oral nicotinamide mononucleotide (NMN), and if so, what dose and safety monitoring are recommended?
In a generally healthy adult with an infection that may reduce nicotinamide adenine dinucleotide (NAD) levels, what oral or parenteral niacin/nicotinamide supplementation is recommended?
What daily oral dose of niacinamide should be given to a patient without liver disease, renal impairment, or allergy to the drug?
Is it safe to prescribe nicotinamide 500 mg twice daily to an 80‑year‑old man with mildly elevated serum creatinine and a normal urine protein‑to‑creatinine ratio?
Is a daily oral dose of 100 mg niacinamide safe for a patient without liver disease, renal impairment, or allergy to the drug?
How should Raynaud phenomenon secondary to an autoimmune disease be evaluated and managed?
Given the decreasing TSH (down to 0.38) and low free T4 (0.43 ng/dL) while on levothyroxine 37.5 µg and liothyronine 5 µg daily, should the thyroid medication regimen be adjusted?
How can AI be implemented in rural healthcare to improve access, early detection, and quality of care?
What is the appropriate management of acute gastroenteritis in a 74-year-old conscious patient with hypertension, diabetes, impaired renal function, and an ejection fraction of 25%?
What is the appropriate amoxicillin dosage for treating impetigo in a 2‑year‑old child?
Does hypertension cause muscle cramps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.